Doctors test 'Virus vs. Bacteria' therapy for tough lung infection
NCT ID NCT07228702
Summary
This study is testing a new approach for a hard-to-treat lung infection caused by Mycobacterium abscessus. A single patient will receive a special virus (called a bacteriophage) designed to kill the bacteria, given through an IV and inhaled, along with standard antibiotics. The main goals are to see if this combination reduces the infection in the lungs and is safe for the patient.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-TUBERCULOUS MYCOBACTERIAL (NTM) PNEUMONIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Vancouver General Hospital Non-Tuberculous Mycobacterial Disease Clinic
Vancouver, British Columbia, V5Z 1M9, Canada
Conditions
Explore the condition pages connected to this study.